Source: International Congress 2015 – Monitoring and phenotyping COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Maaike Telgen (Enschede, Netherlands), Maaike Zuur-Telgen, Paul Van der Valk, Bram Zuur, Job Van der Palen, Huib Kerstjens, Marjolein Brusse-Keizer. Stable state fibrinogen is additive to MR-proADM as a predictor of mortality in COPD patients. Eur Respir J 2015; 46: Suppl. 59, 3362

Member's Comments

No comment yet.

Related content which might interest you: Microalbuminuria as a cardiovascular biomarker in patients with COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Circulating copeptin is associated with mortality irrespectively of exacerbation rate in stable COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 COPDCoRi, an algorithm for predicting the risk of coronaropathy in COPD patients Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014 SP-D as a biomarker for COPD in the Lebanese population Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 CRP as predictor as predictor for late treatment failure in hospitalised patients with AECOPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Association of angiopoietin-like protein 4 with cardiovascular function in patients with COPD Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016 High-sensitivity cardiac troponin T is associated with increased mortality in patients with stable chronic obstructive pulmonary disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Serum BNP levels in COPD, asthma-COPD-overlap-syndrome, smokers and never-smokers Source: International Congress 2016 – Systemic biomarkers Year: 2016 Risk scores for predicting death in COPD patients Source: International Congress 2016 – Highlights in the management of COPD and beyond Year: 2016 Proteinase-inhibitor system state in patients with COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Distribution of blood eosinophil in COPD patients Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 Procalcitonin and proadrenomedullin in COPD patients: Stable state versus exacerbation difference in mortality rate? Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 Role of comorbidities in stable COPD patients mortality Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Predictive factors of exercise capacity decline in patients with COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Prognostic assessment in chronic obstructive pulmonary disease using copeptin: A simplified risk index Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Characteristics and prognostic factors associated with cardiovascular (CV) comorbidity in COPD patients hospitalized for acute exacerbation (AECOPD) Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Cardiovascular status of patients with a severe form of COPD Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015 Plasma surfactant protein D (SP-D) and comorbidity rate in patients with COPD Source: International Congress 2014 – Predictors Year: 2014 Burden of comorbidities and NT-proBNP concentrations in stable COPD patients Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities Year: 2013